Emerging patterns of somatic mutations in cancer (original) (raw)

• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  CAS PubMed Google Scholar
• Stratton, M. R. Exploring the genomes of cancer cells: progress and promise. Science 331, 1553–1558 (2011).
  Article CAS PubMed Google Scholar
• Vogelstein, B. & Kinzler, K. W. The multistep nature of cancer. Trends Genet. 9, 138–141 (1993).
  Article CAS PubMed Google Scholar
• Chin, L., Hahn, W. C., Getz, G. & Meyerson, M. Making sense of cancer genomic data. Genes Dev. 25, 534–555 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Meyerson, M., Gabriel, S. & Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nature Rev. Genet. 11, 685–696 (2010).
  Article CAS PubMed Google Scholar
• Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008). This study demonstrated the promise of unbiased genomic sequencing through the identification of a highly recurrent mutation in a previously unknown oncogene, IDH1 , by using pre-NGS approaches involving PCR amplification and Sanger-based sequencing of more than 20,000 protein-coding genes.
  Article CAS PubMed PubMed Central Google Scholar
• Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006).
  Article CAS PubMed Google Scholar
• Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ward, P. S. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225–234 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510–522 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53–58 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011). This WGS study led to the description of a phenomenon termed chromothripsis, in which up to hundreds of genomic rearrangements take place in a single cellular crisis event.
  Article CAS PubMed PubMed Central Google Scholar
• Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666–677 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Burns, M. B. et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366–370 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Taylor, B. J. et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2, e00534 (2013).
  Article PubMed PubMed Central Google Scholar
• International Cancer Genome Consortium et al. International network of cancer genome projects. Nature 464, 993–998 (2010).
• Creighton, C. J. et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43–49 (2013).
  Article CAS Google Scholar
• Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67–73 (2013).
  Article CAS PubMed Google Scholar
• Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).
• Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).
• Cancer Genome Atlas Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).
• Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011).
• Cancer Genome Atlas Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012).
• Fujimoto, A. et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nature Genet. 44, 760–764 (2012).
  Article CAS PubMed Google Scholar
• Papaemmanuil, E. et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N. Engl. J. Med. 365, 1384–1395 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101–105 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Quesada, V. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nature Genet. 44, 47–52 (2012).
  Article CAS Google Scholar
• Stephens, P. J. et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400–404 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Totoki, Y. et al. High-resolution characterization of a hepatocellular carcinoma genome. Nature Genet. 43, 464–469 (2011).
  Article CAS PubMed Google Scholar
• Cancer Genome Atlas Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059–2074 (2013).
• Wang, K. et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nature Genet. 43, 1219–1223 (2011).
  Article CAS PubMed Google Scholar
• Zang, Z. J. et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nature Genet. 44, 570–574 (2012).
  Article CAS PubMed Google Scholar
• Guichard, C. et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genet. 44, 694–698 (2012).
  Article CAS PubMed Google Scholar
• Li, M. et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nature Genet. 43, 828–829 (2011).
  Article CAS PubMed Google Scholar
• Huang, J. et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nature Genet. 44, 1117–1121 (2012).
  Article CAS PubMed Google Scholar
• Ong, C. K. et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nature Genet. 44, 690–693 (2012).
  Article CAS PubMed Google Scholar
• Garraway, L. A. & Lander, E. S. Lessons from the cancer genome. Cell 153, 17–37 (2013).
  Article CAS PubMed Google Scholar
• Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013). This paper highlights sources of mutational heterogeneity across cancer, which include cancer type, mutational spectrum, gene expression and DNA replication time. The authors developed MutSigCV, a method that corrects for these variations by using patient-specific mutation frequency and spectrum, and gene-specific BMR by incorporating expression level and replication time, to better identify lung cancer-associated genes.
  Article CAS PubMed PubMed Central Google Scholar
• Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251–263 (2012). This study discusses the difficult task of identifying SMGs in cancers that possess a high and heterogeneous BMR. By taking into account mutations in flanking exons to better ascertain a gene-specific BMR, the authors developed the algorithm InVEx to identify melanoma- and lung cancer-associated genes.
  Article CAS PubMed PubMed Central Google Scholar
• Singh, D. et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337, 1231–1235 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Banks, R. E. et al. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res. 66, 2000–2011 (2006).
  Article CAS PubMed Google Scholar
• Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360–363 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539–542 (2011). This study provides another example of the power of unbiased genomic sequencing by identifying a second major ccRCC cancer gene, the SWI/SNF chromatin remodelling gene PBRM1 , targeted by frequent LOF mutations in 41% of samples.
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, B. G. & Roberts, C. W. SWI/SNF nucleosome remodellers and cancer. Nature Rev. Cancer 11, 481–492 (2011).
  Article CAS Google Scholar
• Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206 (1998).
  Article CAS PubMed Google Scholar
• Wong, A. K. et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res. 60, 6171–6177 (2000).
  CAS PubMed Google Scholar
• Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410–1413 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Testa, J. R. et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genet. 43, 1022–1025 (2011).
  Article CAS PubMed Google Scholar
• Pena-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nature Genet. 44, 751–759 (2012).
  Article CAS PubMed Google Scholar
• Hakimi, A. A. et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network. Clin. Cancer Res. 19, 3259–3267 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nature Genet. 45, 860–867 (2013).
  Article CAS PubMed Google Scholar
• Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154–1157 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157–1160 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Nicolas, M. et al. Notch1 functions as a tumor suppressor in mouse skin. Nature Genet. 33, 416–421 (2003).
  Article CAS PubMed Google Scholar
• Extance, A. Alzheimer's failure raises questions about disease-modifying strategies. Nature Rev. Drug Discov. 9, 749–751 (2010).
  Article CAS Google Scholar
• Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002). This study discovered the BRAF V600E mutation in 66% of malignant melanomas and at lower frequency in a wide range of human cancers. The subsequent development of an inhibitor to treat patients with BRAF -mutant metastatic melanoma provided the proof of concept for genomics-informed personalized therapy.
  Article CAS PubMed Google Scholar
• Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502–506 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Krauthammer, M. et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nature Genet. 44, 1006–1014 (2012).
  Article CAS PubMed Google Scholar
• Mok, T. S. Personalized medicine in lung cancer: what we need to know. Nature Rev. Clin. Oncol. 8, 661–668 (2011).
  Article CAS Google Scholar
• Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107–1120 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Rudin, C. M. et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nature Genet. 44, 1111–1116 (2012).
  Article CAS PubMed Google Scholar
• Pleasance, E. D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184–190 (2010).
  Article CAS PubMed Google Scholar
• Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644–648 (2005).
  Article CAS PubMed Google Scholar
• Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nature Genet. 44, 685–689 (2012).
  Article CAS PubMed Google Scholar
• Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239–243 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Seshagiri, S. et al. Recurrent R–spondin fusions in colon cancer. Nature 488, 660–664 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Bass, A. J. et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A–TCF7L2 fusion. Nature Genet. 43, 964–968 (2011).
  Article CAS PubMed Google Scholar
• Banerji, S. et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405–409 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ellis, M. J. et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486, 353–360 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994–1007 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395–399 (2012).
  Article CAS PubMed Google Scholar
• Paterlini-Brechot, P. et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22, 3911–3916 (2003).
  Article CAS PubMed Google Scholar
• Sung, W. K. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nature Genet. 44, 765–769 (2012).
  Article CAS PubMed Google Scholar
• Grimwade, D. & Hills, R. K. Independent prognostic factors for AML outcome. Hematology Am. Soc. Hematol. Educ. Program 385–395 (2009).
• Abdel-Wahab, O. et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114, 144–147 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gelsi-Boyer, V. et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br. J. Haematol. 145, 788–800 (2009).
  Article CAS PubMed Google Scholar
• Makishima, H. et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 24, 1799–1804 (2010).
  Article CAS PubMed Google Scholar
• Ernst, T. et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nature Genet. 42, 722–726 (2010).
  Article CAS PubMed Google Scholar
• Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66–72 (2008). The first WGS report for a human cancer using NGS technology that identified mutations in DNMT3A, IDH1 and IDH2 in human AML.
  Article CAS PubMed PubMed Central Google Scholar
• Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424–2433 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yan, X. J. et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genet. 43, 309–315 (2011).
  Article CAS PubMed Google Scholar
• Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Graubert, T. A. et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nature Genet. 44, 53–57 (2012).
  Article CAS Google Scholar
• Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264–278 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshida, K. et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64–69 (2011). The first study to report frequent novel pathway mutations involving multiple components of the RNA splicing machinery, which occurred in a mutually exclusive manner, specific to myeloid neoplasms showing features of myelodysplasia. Frequent mutations in spliceosomal genes have since been discovered in a number of haematological malignancies and solid tumours.
  Article CAS PubMed Google Scholar
• Walter, M. J. et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia 27, 1275–1282 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Makishima, H. et al. Somatic SETBP1 mutations in myeloid malignancies. Nature Genet. 45, 942–946 (2013).
  Article CAS PubMed Google Scholar
• Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497–2506 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Quesada, V., Ramsay, A. J. & Lopez-Otin, C. Chronic lymphocytic leukemia with SF3B1 mutation. N. Engl. J. Med. 366, 2530 (2012).
  Article CAS PubMed Google Scholar
• Fabbri, G. et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J. Exp. Med. 208, 1389–1401 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758–764 (2007).
  Article CAS PubMed Google Scholar
• Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471, 235–239 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298–303 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lohr, J. G. et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl Acad. Sci. USA 109, 3879–3884 (2012).
  Article PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189–195 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nature Genet. 43, 830–837 (2011).
  Article CAS PubMed Google Scholar
• Kridel, R. et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 119, 1963–1971 (2012).
  Article CAS PubMed Google Scholar
• Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467–472 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Walker, B. A. et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood 120, 1077–1086 (2012).
  Article CAS PubMed Google Scholar
• Zenz, T. et al. TP53 mutation and survival in chronic lymphocytic leukemia. J. Clin. Oncol. 28, 4473–4479 (2010).
  Article PubMed Google Scholar
• Trbusek, M. et al. Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia. J. Clin. Oncol. 29, 2703–2708 (2011).
  Article CAS PubMed Google Scholar
• Austen, B. et al. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. Blood 106, 3175–3182 (2005).
  Article CAS PubMed Google Scholar
• Treon, S. P. et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N. Engl. J. Med. 367, 826–833 (2012).
  Article CAS PubMed Google Scholar
• Kiel, M. J. et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J. Exp. Med. 209, 1553–1565 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Koskela, H. L. et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N. Engl. J. Med. 366, 1905–1913 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Tiacci, E. et al. BRAF mutations in hairy-cell leukemia. N. Engl. J. Med. 364, 2305–2315 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dietrich, S. et al. BRAF inhibition in refractory hairy-cell leukemia. N. Engl. J. Med. 366, 2038–2040 (2012).
  Article PubMed Google Scholar
• Kuo, K. T. et al. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am. J. Pathol. 174, 1597–1601 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, S. et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228–231 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wiegand, K. C. et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363, 1532–1543 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Van Raamsdonk, C. D. et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599–602 (2009).
  Article CAS PubMed Google Scholar
• Van Raamsdonk, C. D. et al. Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363, 2191–2199 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012).
  Article CAS PubMed Google Scholar
• Tefferi, A. et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110, 1092–1097 (2007).
  Article CAS PubMed Google Scholar
• Grimwade, D. et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116, 354–365 (2010).
  Article CAS PubMed Google Scholar
• Greenberg, P. L. et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120, 2454–2465 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Bejar, R. et al. Clinical effect of point mutations in myelodysplastic syndromes. N. Engl. J. Med. 364, 2496–2506 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bejar, R. et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J. Clin. Oncol. 30, 3376–3382 (2012).
  Article PubMed PubMed Central Google Scholar
• Patel, J. P. et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N. Engl. J. Med. 366, 1079–1089 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Schlenk, R. F. et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358, 1909–1918 (2008).
  Article CAS PubMed Google Scholar
• Rosenbloom, K. R. et al. ENCODE data in the UCSC genome browser: year 5 update. Nucleic Acids Res. 41, D56–D63 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013).
  Article CAS PubMed Google Scholar
• Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957–959 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Yates, L. R. & Campbell, P. J. Evolution of the cancer genome. Nature Rev. Genet. 13, 795–806 (2012).
  Article CAS PubMed Google Scholar
• Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nature Biotech. 30, 413–421 (2012).
  Article CAS Google Scholar
• Greenman, C., Wooster, R., Futreal, P. A., Stratton, M. R. & Easton, D. F. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173, 2187–2198 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Parmigiani, G. et al. Statistical methods for the analysis of cancer genome sequencing data. Johns Hopkins University, Dept. of Biostatistics Working Papers [online], (2007).
  Google Scholar
• Youn, A. & Simon, R. Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 27, 175–181 (2011).
  Article CAS PubMed Google Scholar
• Ding, L. et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069–1075 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869–873 (2010).
  Article CAS PubMed Google Scholar
• Getz, G. et al. Comment on “The consensus coding sequences of human breast and colorectal cancers”. Science 317, 1500 (2007).
  Article CAS PubMed Google Scholar
• Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589–1598 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191–196 (2010).
  Article CAS PubMed Google Scholar
• Schuster-Bockler, B. & Lehner, B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488, 504–507 (2012).
  Article CAS PubMed Google Scholar
• Hellmann, I. et al. Why do human diversity levels vary at a megabase scale? Genome Res. 15, 1222–1231 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Stamatoyannopoulos, J. A. et al. Human mutation rate associated with DNA replication timing. Nature Genet. 41, 393–395 (2009).
  Article CAS PubMed Google Scholar
• Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nature Methods 7, 248–249 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sim, N. L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452–457 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Carter, H. et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 69, 6660–6667 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98–110 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Shibata, T. et al. Cancer related mutations in NRF2 impair its recognition by Keap1–Cul3 E3 ligase and promote malignancy. Proc. Natl Acad. Sci. USA 105, 13568–13573 (2008).
  Article PubMed PubMed Central Google Scholar
• Ciriello, G., Cerami, E., Sander, C. & Schultz, N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 22, 398–406 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Vandin, F., Upfal, E. & Raphael, B. J. Algorithms for detecting significantly mutated pathways in cancer. J. Computat. Biol. 18, 507–522 (2011).
  Article CAS Google Scholar
• Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117–122 (2005).
  Article CAS PubMed Google Scholar
• Ruark, E. et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 493, 406–410 (2013).
  Article CAS PubMed Google Scholar
• Heyer, J., Kwong, L. N., Lowe, S. W. & Chin, L. Non-germline genetically engineered mouse models for translational cancer research. Nature Rev. Cancer 10, 470–480 (2010).
  Article CAS Google Scholar
• Kim, M. et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125, 1269–1281 (2006).
  Article CAS PubMed Google Scholar
• Maser, R. S. et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 447, 966–971 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zender, L. et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253–1267 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Wartman, L. D. et al. Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. J. Clin. Invest. 121, 1445–1455 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90–94 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506–510 (2012). This paper provided important insights into the evolution of clonal populations in AML throughout cancer treatment using longitudinal sampling and WGS analysis.
  Article CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012). This study examined intra-tumour heterogeneity by profiling spatially separated tumour biopsy samples from primary and associated metastatic samples with various genomic platforms, including WES. The analysis demonstrates how single tumour biopsy samples underestimated the genomic landscape and presents the challenges that intra-tumour heterogeneity pose to the advancement of personalized medicine.
  Article CAS PubMed PubMed Central Google Scholar
• Tao, Y. et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc. Natl Acad. Sci. USA 108, 12042–12047 (2011).
  Article PubMed PubMed Central Google Scholar
• Govindan, R. et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150, 1121–1134 (2012).
  Article CAS PubMed PubMed Central Google Scholar